Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active site. 2009

Daniel M Himmel, and Karen A Maegley, and Tom A Pauly, and Joseph D Bauman, and Kalyan Das, and Chhaya Dharia, and Arthur D Clark, and Kevin Ryan, and Michael J Hickey, and Robert A Love, and Stephen H Hughes, and Simon Bergqvist, and Eddy Arnold
Center for Advanced Biotechnology and Medicine and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854-8021, USA.

Novel inhibitors are needed to counteract the rapid emergence of drug-resistant HIV variants. HIV-1 reverse transcriptase (RT) has both DNA polymerase and RNase H (RNH) enzymatic activities, but approved drugs that inhibit RT target the polymerase. Inhibitors that act against new targets, such as RNH, should be effective against all of the current drug-resistant variants. Here, we present 2.80 A and 2.04 A resolution crystal structures of an RNH inhibitor, beta-thujaplicinol, bound at the RNH active site of both HIV-1 RT and an isolated RNH domain. beta-thujaplicinol chelates two divalent metal ions at the RNH active site. We provide biochemical evidence that beta-thujaplicinol is a slow-binding RNH inhibitor with noncompetitive kinetics and suggest that it forms a tropylium ion that interacts favorably with RT and the RNA:DNA substrate.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D012260 Ribonucleases Enzymes that catalyze the hydrolysis of ester bonds within RNA. EC 3.1.-. Nucleases, RNA,RNase,Acid Ribonuclease,Alkaline Ribonuclease,Ribonuclease,RNA Nucleases,Ribonuclease, Acid,Ribonuclease, Alkaline
D014334 Tropolone A seven-membered aromatic ring compound. It is structurally related to a number of naturally occurring antifungal compounds (ANTIFUNGAL AGENTS).
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D020134 Catalytic Domain The region of an enzyme that interacts with its substrate to cause the enzymatic reaction. Active Site,Catalytic Core,Catalytic Region,Catalytic Site,Catalytic Subunit,Reactive Site,Active Sites,Catalytic Cores,Catalytic Domains,Catalytic Regions,Catalytic Sites,Catalytic Subunits,Core, Catalytic,Cores, Catalytic,Domain, Catalytic,Domains, Catalytic,Reactive Sites,Region, Catalytic,Regions, Catalytic,Site, Active,Site, Catalytic,Site, Reactive,Sites, Active,Sites, Catalytic,Sites, Reactive,Subunit, Catalytic,Subunits, Catalytic

Related Publications

Daniel M Himmel, and Karen A Maegley, and Tom A Pauly, and Joseph D Bauman, and Kalyan Das, and Chhaya Dharia, and Arthur D Clark, and Kevin Ryan, and Michael J Hickey, and Robert A Love, and Stephen H Hughes, and Simon Bergqvist, and Eddy Arnold
December 2006, ACS chemical biology,
Daniel M Himmel, and Karen A Maegley, and Tom A Pauly, and Joseph D Bauman, and Kalyan Das, and Chhaya Dharia, and Arthur D Clark, and Kevin Ryan, and Michael J Hickey, and Robert A Love, and Stephen H Hughes, and Simon Bergqvist, and Eddy Arnold
July 2014, Journal of molecular biology,
Daniel M Himmel, and Karen A Maegley, and Tom A Pauly, and Joseph D Bauman, and Kalyan Das, and Chhaya Dharia, and Arthur D Clark, and Kevin Ryan, and Michael J Hickey, and Robert A Love, and Stephen H Hughes, and Simon Bergqvist, and Eddy Arnold
July 2018, Journal of virology,
Daniel M Himmel, and Karen A Maegley, and Tom A Pauly, and Joseph D Bauman, and Kalyan Das, and Chhaya Dharia, and Arthur D Clark, and Kevin Ryan, and Michael J Hickey, and Robert A Love, and Stephen H Hughes, and Simon Bergqvist, and Eddy Arnold
August 2010, Journal of virology,
Daniel M Himmel, and Karen A Maegley, and Tom A Pauly, and Joseph D Bauman, and Kalyan Das, and Chhaya Dharia, and Arthur D Clark, and Kevin Ryan, and Michael J Hickey, and Robert A Love, and Stephen H Hughes, and Simon Bergqvist, and Eddy Arnold
October 2017, Antimicrobial agents and chemotherapy,
Daniel M Himmel, and Karen A Maegley, and Tom A Pauly, and Joseph D Bauman, and Kalyan Das, and Chhaya Dharia, and Arthur D Clark, and Kevin Ryan, and Michael J Hickey, and Robert A Love, and Stephen H Hughes, and Simon Bergqvist, and Eddy Arnold
November 2019, ACS infectious diseases,
Daniel M Himmel, and Karen A Maegley, and Tom A Pauly, and Joseph D Bauman, and Kalyan Das, and Chhaya Dharia, and Arthur D Clark, and Kevin Ryan, and Michael J Hickey, and Robert A Love, and Stephen H Hughes, and Simon Bergqvist, and Eddy Arnold
August 2012, Yao xue xue bao = Acta pharmaceutica Sinica,
Daniel M Himmel, and Karen A Maegley, and Tom A Pauly, and Joseph D Bauman, and Kalyan Das, and Chhaya Dharia, and Arthur D Clark, and Kevin Ryan, and Michael J Hickey, and Robert A Love, and Stephen H Hughes, and Simon Bergqvist, and Eddy Arnold
December 2016, The Journal of biological chemistry,
Daniel M Himmel, and Karen A Maegley, and Tom A Pauly, and Joseph D Bauman, and Kalyan Das, and Chhaya Dharia, and Arthur D Clark, and Kevin Ryan, and Michael J Hickey, and Robert A Love, and Stephen H Hughes, and Simon Bergqvist, and Eddy Arnold
January 1991, Archives of virology,
Daniel M Himmel, and Karen A Maegley, and Tom A Pauly, and Joseph D Bauman, and Kalyan Das, and Chhaya Dharia, and Arthur D Clark, and Kevin Ryan, and Michael J Hickey, and Robert A Love, and Stephen H Hughes, and Simon Bergqvist, and Eddy Arnold
November 2012, Chemical biology & drug design,
Copied contents to your clipboard!